FDA
approval
· 2021-11-03
FDA Approved: EXCEDRIN MIGRAINE GELTABS — Supplemental Application (Haleon US Holdings LLC)
Summary
The FDA approved a supplemental application to market Excedrin Migraine Geltabs, a new dosage form of the combination product containing acetaminophen, aspirin,…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for EXCEDRIN MIGRAINE GELTABS (ACETAMINOPHEN, ASPRIN, CAFFEINE)